We are live on ! Find out more
ZAM

Zevin Asset Management Portfolio holdings

AUM $723M
1-Year Est. Return 15.62%
This Fund
S&P 500
This Quarter Est. Return
+8.41%
1 Year Est. Return
+15.62%
3 Year Est. Return
+57.49%
5 Year Est. Return
+80.59%
10 Year Est. Return
+296.42%
AUM
$460M
AUM Growth
+$37.1M
Cap. Flow
+$2.02M
Cap. Flow %
0.44%
Top 10 Hldgs %
39.32%
Holding
83
New
7
Increased
23
Reduced
28
Closed
6

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.56M
2
PNC icon
PNC Financial Services
PNC
+$741K
3
AMZN icon
Amazon
AMZN
+$667K
4
CL icon
Colgate-Palmolive
CL
+$664K
5
KR icon
Kroger
KR
+$574K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.58M
2
ADP icon
Automatic Data Processing
ADP
+$1.24M
3
AAPL icon
Apple
AAPL
+$1.13M
4
ULTA icon
Ulta Beauty
ULTA
+$956K
5
VZ icon
Verizon
VZ
+$750K

Sector Composition

Rank Sector Weight
1 Technology 16.62%
2 Financials 14.7%
3 Consumer Discretionary 14.56%
4 Consumer Staples 12.19%
5 Healthcare 10.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVS icon
26
Novartis
NVS
$302B
$8.15M 1.77%
89,888
+937
+1% +$78.9K
ECL icon
27
Ecolab
ECL
$79.8B
$7.93M 1.72%
54,501
+1,272
+2% +$187K
EXPD icon
28
Expeditors International
EXPD
$22.3B
$7.32M 1.59%
70,469
+4,570
+7% +$471K
AZN icon
29
AstraZeneca
AZN
$269B
$7.1M 1.54%
+52,344
New +$6.56M
DLR icon
30
Digital Realty Trust
DLR
$69.6B
$6.3M 1.37%
62,801
+396
+0.6% +$40.4K
PYPL icon
31
PayPal
PYPL
$50.3B
$5.77M 1.25%
80,960
-2,834
-3% -$227K
TRU icon
32
TransUnion
TRU
$16B
$3.59M 0.78%
63,313
-6,236
-9% -$365K
HD icon
33
Home Depot
HD
$337B
$3.54M 0.77%
11,193
-663
-6% -$202K
PNC icon
34
PNC Financial Services
PNC
$99.1B
$3.2M 0.69%
20,235
+4,711
+30% +$741K
PG icon
35
Procter & Gamble
PG
$340B
$1.17M 0.25%
7,711
-552
-7% -$77.4K
KUB
36
DELISTED
KUBOTA CORPORATION (ONE ADS REP 5 SHS COM)
KUB
$1.09M 0.24%
15,939
-757
-5% -$51.6K
ABT icon
37
Abbott
ABT
$188B
$1.08M 0.23%
9,796
-40
-0.4% -$4.14K
MRK icon
38
Merck
MRK
$322B
$869K 0.19%
7,836
– –
DOC icon
39
Healthpeak Properties
DOC
$15.5B
$858K 0.19%
34,242
-895
-3% -$21.8K
GILD icon
40
Gilead Sciences
GILD
$165B
$722K 0.16%
8,410
– –
PFE icon
41
Pfizer
PFE
$143B
$518K 0.11%
10,110
– –
SPY icon
42
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$493K 0.11%
1,289
-325
-20% -$125K
PEP icon
43
PepsiCo
PEP
$196B
$489K 0.11%
2,705
– –
SUSA icon
44
iShares ESG Optimized MSCI USA ETF
SUSA
$3.95B
$487K 0.11%
5,915
– –
K
45
DELISTED
Kellanova
K
$485K 0.11%
7,253
– –
MCD icon
46
McDonald's
MCD
$193B
$482K 0.1%
1,830
– –
AMAT icon
47
Applied Materials
AMAT
$347B
$469K 0.1%
4,814
-788
-14% -$75.6K
MMM icon
48
3M
MMM
$91.8B
$323K 0.07%
3,222
– –
SBUX icon
49
Starbucks
SBUX
$119B
$308K 0.07%
3,105
-32
-1% -$3.02K
XOM icon
50
ExxonMobil
XOM
$650B
$305K 0.07%
2,769
– –
1
2
3

Similar funds

PPW
Pasadena Private Wealth Pasadena, California $723M AUM 18.72% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
FFM
FengHe Fund Management Singapore $724M AUM 196.18% 1-Year Est. Return
AGAM
Avalon Global Asset Management San Francisco, California $724M AUM 52.97% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
TFHU
TLT Family Holdco ULC Toronto $724M AUM 24.23% 1-Year Est. Return
FAN
Financial Advisors Network Tustin, California $724M AUM 14.91% 1-Year Est. Return

Zevin Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Zevin Asset Management held 83 positions worth $460M, up 8.8% from $423M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Zevin Asset Management's Q4 2022 filing shows 7 new, 23 increased, 28 reduced and 6 closed positions. Its largest new stake was AstraZeneca: 52,344 shares worth $7.1M. The largest sale was GSK, an estimated $1.58M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Zevin Asset Management's largest Q4 2022 buy was AstraZeneca: 52,344 shares worth $7.1M.
  • Zevin Asset Management added most to PNC Financial Services in Q4 2022, an estimated $741K increase.
  • Zevin Asset Management's biggest Q4 2022 reduction was Automatic Data Processing, cutting an estimated $1.24M.
  • Zevin Asset Management fully exited GSK in Q4 2022, selling an estimated $1.58M.
  • Zevin Asset Management's ten largest holdings make up 39% of its $460M portfolio in Q4 2022.
  • Zevin Asset Management opened 7 new positions and closed 6 in Q4 2022.
  • Zevin Asset Management's portfolio value rose 8.8% quarter-over-quarter to $460M.

Based on Zevin Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.